Page results
-
Nailesh Rambhai became an associate non-executive director at UCLH in April 2022. A lawyer by background, he has also acted as group counsel and company secretary to a number of firms including the Coventry Building Society and Petronas.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
His Royal Highness the Prince of Wales officially opened the University College Hospital Grafton Way Building today.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
As photographer Tom Pilston searched for a way to make his contribution during the Covid-19 pandemic, he cast around for a project which would allow him to pay tribute to the NHS he describes as "all that is good about the UK ... humane and caring, hard-working, sensitive and strong".
-
Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
File results
-
FOI/2022/0048 - Cancer deaths in relation to Covid-19
-
FOI/2022/0069 - Trust’s flexible endoscope inventory
-
FOI/2022/0094 - Emergency Covid funding - private FM contractors
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0118 - Contact centre/ Call centre contracts
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0163 - Ongoing staff absence due to COVID-19
-
FOI/2022/0166 - Routine GP referrals made to Cardiology, Gynaecology and Neurology
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)